Back to Startups

Micot

About Micot

Micot has established a bispecific peptide technology platform, specializing in the development of innovative drugs, particularly in the peptide and protein drug sector.

Business Information
Target Customers
pharmaceutical companies biotechnology firms research institutions
Industry Categories
Bioscience & Disease Healthcare Systems Deep Tech
Business Model
Revenue Model B2B
Pricing Strategy Custom pricing based on partnerships and collaborations
Sales Channels direct sales, partnerships with pharmaceutical companies
Funding Timeline
Round Date Amount Investors
Series D Jul 04, 2025 $14.0M Zheshang Venture Capital
Founders

No founder information available.

Investors
Z
Recent Mentions
chuminhua432
Minhua Chu @chuminhua432
Jul 04, 2025

🇨🇳 Shaanxi #Micot announced the completion of over 100 million RMB in Series D financing. This round was led by Zheshang Venture Capital. Founded in Xi'an in 2007, Micot has established a bispecific peptide technology platform. Its core product, MT1013, bispecific peptide as a